Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
backgroundPain is common after lung surgery, yet non-pharmacological strategies remain underutilized. Behavioral Speech Therapy (BST) may improve recovery for thoracoscopic surgery patients. PURPOSE: To evaluate whether BST reduces pain and improves physical function after thoracoscopic lung cancer surgery.
methodsThis secondary analysis of a registered trial (ChiCTR2400084313, originally evaluating BST for postoperative cough) used data from 112 patients who were assigned to routine care alone (control) or routine care plus BST (intervention). Pain (VAS, range 0-10 scores) and function (ECOG score, range 0-4 scores) were assessed at baseline (preoperative), 1 month, and 3 months postoperatively. All outcomes were evaluated by blinded assessors at three time points: preoperative (T0), 1 month post-surgery (T1), and 3 months post-surgery (T2). A mixed-effects model was used for analysis.
resultsAt 1 month, the control group's VAS worsened more than the BST group (MD -0.63, 95% CI: -1.07 to -0.19, P = 0.01) in Model 3. At 3 months, the between-group difference favored BST (MD -0.88, 95% CI: -1.32 to -0.44, P < 0.001). ECOG analysis showed a significant between-group difference at 1 month favoring BST (MD -0.27, 95% CI: -0.49 to -0.06, P = 0.01). The difference at 3 months was not statistically significant (MD -0.20, 95% CI: -0.42 to 0.01, P = 0.06).
conclusionsBST reduces postoperative pain at 1 and 3 months and improves physical function at 1 month, suggesting its potential as a low-risk, non-pharmacological adjunct for pain management within enhanced recovery after surgery pathways.
Indexed as
Identifiers
42611082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.